Doru Paul, MD, is triple board-certified in medical oncology, hematology, and internal medicine and is an Associate Professor of Clinical Medicine at Weill Cornell Medical College. A JAK2 mutation can ...
Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.
A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers ...
A Frederick oncologist and his practice agreed to pay more than $1.4 million to settle allegations of submitting fraudulent billing claims. Dr. Mouhamad Bazzi and Progressive Oncology & Hematology, ...
TGFβ signalling is tumour suppressive in epithelial cells, whereas it can promote invasion and metastasis during the later stages of carcinoma progression. During tumour progression, tumour cells ...
Lu]Lu-edotreotide led to statistically significant and clinically meaningful improvements in progression-free survival.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results